Phagenesis

Developer of medical devices for the treatment of Neurogenic dysphagia

placeManchester, England, United Kingdom calendar_todayFounded 2007 groups22 employees language phagenesis.com

Registered entities

Innovation

18 patent families (13 granted) — focus: Human necessities; filing pace steady. Cited 2,767 times.

YearFilings
20154
20166
20178
20185
20194
20206
20213
202211
20238
20248
20257
20263

Investor mix

12 investors on record; lead investors include Sectoral, EQT; 1 has since exited.

Investor typeCountShare
Venture capital650%
Private equity217%
Accelerator & incubator18%
Other / undisclosed325%
Coming soon